Cost-of-illness of psoriasis - results of a German cross-sectional study.
J Eur Acad Dermatol Venereol
; 32(1): 174-180, 2018 Jan.
Article
en En
| MEDLINE
| ID: mdl-28857297
ABSTRACT
BACKGROUND:
Though psoriasis poses a substantial chronic socio-economic burden, few studies have addressed the economic impact in Germany.OBJECTIVES:
The objective was to evaluate the annual costs of psoriasis in Germany from the societal perspective.METHODS:
A cross-sectional study was performed in randomly selected German dermatology practices and clinics in 2013/2014 using standardized questionnaires of illness-related costs. Costs were grouped by perspective and category as well as analysed by sex and age. Group differences were tested by non-parametric tests.RESULTS:
Complete data were obtained from 1158 patients in 132 centres. Annual average costs for patients with psoriasis total costs 5543 ± 8044, systemic treatment costs (paid by the statutory health insurances [SHI]) 3733 ± 7322, out-of-pocket costs 224 ± 406, total SHI costs 4940 ± 7533, direct costs 5164 ± 7581 and indirect costs 379 ± 2087. Significant higher costs in male and significant lower costs in 65+-year-old patients were found.CONCLUSIONS:
Psoriasis induces a considerable economic burden. Between 2003 and 2014, costs have markedly shifted from hospital, out-of-pocket and indirect costs towards systemic drug costs.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Psoriasis
/
Costos de la Atención en Salud
/
Gastos en Salud
/
Costo de Enfermedad
/
Honorarios y Precios
Tipo de estudio:
Clinical_trials
/
Health_economic_evaluation
/
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
Europa
Idioma:
En
Revista:
J Eur Acad Dermatol Venereol
Asunto de la revista:
DERMATOLOGIA
/
DOENCAS SEXUALMENTE TRANSMISSIVEIS
Año:
2018
Tipo del documento:
Article
País de afiliación:
Alemania